Commercialisation. (a) The Licensee shall use commercially reasonable endeavours to develop a Complement Factor I therapy. (b) [**]
Appears in 2 contracts
Sources: Exclusive Patent and Non Exclusive Know How Licence Agreement (Gyroscope Therapeutics Holdings LTD), Exclusive Patent and Non Exclusive Know How Licence Agreement (Gyroscope Therapeutics Holdings LTD)